Phase 2 PRIMUS-AD Trial to Test Anti-Amyloid Oligomer PRI-002 in Alzheimer Disease
Unveiling the Future: Novel Therapies in the Fight Against Alzheimer’s Disease The relentless pursuit of effective Alzheimer’s disease (AD) treatments continues to captivate the medical and scientific communities. Recent developments, like the PRIMUS-AD study, spotlight the potential of innovative approaches beyond traditional plaque-clearing antibodies. Let’s dive into these exciting advancements and explore the potential future … Read more